Pharmaceutical Technology Europe, May 1, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology Europe, May 1, 2012
News
News
By Stephanie Sutton
EMA Toughens up on Transparency
Ingredients
Seeking New Chemocatalytic and Biocatalytic Solutions
By Patricia Van Arnum
Advances in palladium-catalysed hydrogenation, visible-light photocatalysis and improved chemocatalytic approaches for making heterocyclic compounds are some recent industry developments.
Outsourcing Review
Channeling Steve Jobs
By Jim Miller
Service providers must focus on delivering a superior customer experience.
Editor's Comment
Supply Chain Lessons
By Angie Drakulich
Once again, Apple is doing something the rest of the world should be paying attention to, only this time it's about the company's approach to managing the global supply chain—even when things go wrong.
Agent in Place
All Eyes Alert
It's better to catch costly mistakes in the laboratory before they reach the accounting department.
Ask the Expert
Preventing Contamination with Preservatives
If a product does not have its own antimicrobial properties, then a preservative must be used to ensure microbiological safety.
Special Feature
Pan Coating and Scale-Up: a Practical Guide Based on First Principles
By Abishek Kathuria
There are various theories about how to scale up a solid dosage coating operation in a pan coater. This article provides a basic process understanding and scale-up theory based on first principles.
Industry Insider
Taxing Times for French Pharma
By Nathan Jessop
As the French Presidential campaign is underway, and politicians collaborate with businesses to revive a flagging economy, the pharmaceutical industry seizes the chance to lobby for equitable taxation to give the sector a much-needed boost.
Interview
Atomic Force Microscopy
By Mark Leaper
An analytical technique that is receiving increased attention in the pharmaceutical industry is atomic force microscopy. We interview Mark Leaper from the UK's De Montfort University to find out more about this technology.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here